Product Images Losartan Potassium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Losartan Potassium NDC 70518-0245 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
MM2 - Losartan Potassium 50mg 70518 0245 01
This is a prescription medicine with the name Losartan Potassium. Each package contains 90 tablets with a strength of 50mg each. The manufacturer of the medicine is Aurohindo Pharma Ltd. It is recommended to keep this medication away from children. The directions for use can be found in the package insert. The medication should be stored at a temperature between 20-25°C (68-77°F) with excursions at 15-30°C (59-86°F). It was packaged by RemedyRepack Inc. located in Indiana, PA.*
Losartan Potassium 50mg 70518 0245 02
Losartan Potassium is a tablet of 50 mg strength, available in a pack size of 60, manufactured by Aurohindo Pharma Ltd. The prescription drug is packaged by RemedyRepack Inc. The recommended storage temperature for the tablet is between 20-25°C (83-77°F), excursion permitted up to 15-30°C (53-86°F), as per USP guidelines. The package insert should be referred to for directions for use. The drug must be kept out of children's reach. The NDC number for RX-only Losartan Potassium 50 mg tablet is 70518-0245-02, and the Source NDC is 65862-0202-99.*
Remedy Label
Losartan Potassium is a drug available in the form of a tablet with a strength of 50mg, packed by RemedyRepack INC. The package contains 30 tablets and the directions for use are provided in the package insert. The drug should be stored at a temperature between 20-25°C (53-86°F), and it is for Rx only. The manufacturer is Aurohindo Pharma Ltd., located in Nagar, India. The NDC # is 70518-0245-00, and it should be kept out of the reach of children. The other mentioned numbers are not available for interpretation.*
Figure1 - losartan fig1
Figure2 - losartan fig2
Figure 3 - losartan fig3
The text provided is a table showing the breakdown of primary endpoint events within demographic subgroups. The subgroups are categorized by age, gender, race, and a few other factors. The table is difficult to read due to errors in the and missing information.*
Figure-4 - losartan fig4
This is a table showing the percentage of patients with an event related to the use of Losttan Potassium compared to a placebo. The table indicates that 60% of patients with event occurred with Losttan Potassium and 40% with placebo. The risk reduction is mentioned as 16.1% with p-value equal to 0.022. It seems that Losttan Potassium was being tested for its effectiveness in reducing the occurrence of the event.*
Chemical Structure - losartan str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.